Analysis of COVID-19 inpatients in France during first lockdown of 2020 using explainability methods

被引:0
作者
Jean-Baptiste Excoffier
Noémie Salaün-Penquer
Matthieu Ortala
Mathilde Raphaël-Rousseau
Christos Chouaid
Camille Jung
机构
[1] Kaduceo,Department of Medical Information
[2] CHI,Department of Pneumology
[3] CHI,Clinical Research Center
[4] Inserm U955,undefined
[5] UPEC,undefined
[6] IMRB,undefined
[7] CHI,undefined
来源
Medical & Biological Engineering & Computing | 2022年 / 60卷
关键词
COVID-19; Machine learning; Explainable artificial intelligence; Instance selection;
D O I
暂无
中图分类号
学科分类号
摘要
The COVID-19 pandemic rapidly puts a heavy pressure on hospital centers, especially on intensive care units. There was an urgent need for tools to understand typology of COVID-19 patients and identify those most at risk of aggravation during their hospital stay. Data included more than 400 patients hospitalized due to COVID-19 during the first wave in France (spring of 2020) with clinical and biological features. Machine learning and explainability methods were used to construct an aggravation risk score and analyzed feature effects. The model had a robust AUC ROC Score of 81%. Most important features were age, chest CT Severity and biological variables such as CRP, O2 Saturation and Eosinophils. Several features showed strong non-linear effects, especially for CT Severity. Interaction effects were also detected between age and gender as well as age and Eosinophils. Clustering techniques stratified inpatients in three main subgroups (low aggravation risk with no risk factor, medium risk due to their high age, and high risk mainly due to high CT Severity and abnormal biological values). This in-depth analysis determined significantly distinct typologies of inpatients, which facilitated definition of medical protocols to deliver the most appropriate cares for each profile.
引用
收藏
页码:1647 / 1658
页数:11
相关论文
共 119 条
[1]  
Stoecklin SB(2020)First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures Eurosurveillance 25 2000094-436
[2]  
Rolland P(2672)Direct comparison of clinical characteristics, outcomes and risk prediction in patients with COVID-19 and controls—a prospective cohort study J Clin Med 10 2021-1399
[3]  
Silue Y(2020)Factors associated with COVID-19-related death using openSAFELY Nature 584 430-13
[4]  
Mailles A(2020)Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score Clin Infect Dis 71 1393-1089
[5]  
Campese C(2021)Early risk assessment for COVID-19 patients from emergency department data using machine learning Sci Rep 11 1-9
[6]  
Simondon A(2020)Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19 JAMA Intern Med 180 1081-26
[7]  
Lampart M(2020)Developing a COVID-19 mortality risk prediction model when individual-level data are not available Nat Commun 11 1-14
[8]  
Rüegg M(2020)Machine learning to predict mortality and critical events in a cohort of patients with COVID-19 in New York city: model development and validation J Med Internet Res 22 e24018-e67
[9]  
Jauslin AS(2019)Risk stratification: a two-step process for identifying your sickest patients Fam Pract Manag 26 21-65
[10]  
Simon NR(2018)Random forest versus logistic regression: a large-scale benchmark experiment BMC Bioinform 19 1-2279